BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 30629754)

  • 1. Molecular profiling of the biphasic components of hepatic carcinosarcoma by the use of targeted next-generation sequencing.
    Zhang X; Bai Q; Xu Y; Wang W; Chen L; Han J; Zhu H; Zhang Z; Hou Y; Zhou J; Zhou Y; Ji Y
    Histopathology; 2019 May; 74(6):944-958. PubMed ID: 30629754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maxillary carcinosarcoma: Identification of a novel MET mutation in both carcinomatous and sarcomatous components through next generation sequencing.
    Ando M; Saito Y; Morikawa T; Omura G; Kobayashi K; Akashi K; Yoshida M; Ebihara Y; Fujimoto C; Fukayama M; Yamasoba T; Asakage T
    Head Neck; 2015 Dec; 37(12):E179-85. PubMed ID: 25782598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromosomal imbalances in primary hepatic carcinosarcoma.
    Schaefer IM; Schweyer S; Kuhlgatz J
    Hum Pathol; 2012 Aug; 43(8):1328-33. PubMed ID: 22406375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary cutaneous carcinosarcoma: insights into its clonal origin and mutational pattern expression analysis through next-generation sequencing.
    Paniz Mondolfi AE; Jour G; Johnson M; Reidy J; Cason RC; Barkoh BA; Benaim G; Singh R; Luthra R
    Hum Pathol; 2013 Dec; 44(12):2853-60. PubMed ID: 24071013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pancreatic carcinosarcoma with the same KRAS gene mutation in both carcinomatous and sarcomatous components: molecular evidence for monoclonal origin of the tumour.
    Bai Q; Zhang X; Zhu X; Wang L; Huang D; Cai X; Zhou X; Wang J; Sheng W
    Histopathology; 2016 Sep; 69(3):393-405. PubMed ID: 27307095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic carcinosarcoma: evidence of polyclonal origin based on microsatellite analysis.
    Gu YJ; Zhu YY; Lu XY; Zhao Q; Cong WM
    Pathol Res Pract; 2015 Dec; 211(12):905-10. PubMed ID: 26452486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular and clinicopathological analyses of esophageal carcinosarcoma with special reference to morphological change.
    Tsuyama S; Saito T; Akazawa Y; Yanai Y; Yatagai N; Akaike K; Hayashi T; Suehara Y; Takahashi F; Takamochi K; Hashimoto T; Kajiyama Y; Tsurumaru M; Fukunaga T; Yao T
    Virchows Arch; 2019 Oct; 475(4):415-424. PubMed ID: 31444625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sarcomatoid adrenocortical carcinoma: a comprehensive pathological, immunohistochemical, and targeted next-generation sequencing analysis.
    Papathomas TG; Duregon E; Korpershoek E; Restuccia DF; van Marion R; Cappellesso R; Sturm N; Rossi G; Coli A; Zucchini N; Stoop H; Oosterhuis W; Ventura L; Volante M; Fassina A; Dinjens WN; Papotti M; de Krijger RR
    Hum Pathol; 2016 Dec; 58():113-122. PubMed ID: 27589897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing inter-component heterogeneity of biphasic uterine carcinosarcomas.
    Liu Y; Weber Z; San Lucas FA; Deshpande A; Jakubek YA; Sulaiman R; Fagerness M; Flier N; Sulaiman J; Davis CM; Fowler J; Starks D; Rojas-Espaillat L; Lazar AJ; Davies GE; Ehli EA; Scheet P
    Gynecol Oncol; 2018 Nov; 151(2):243-249. PubMed ID: 30194005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary carcinosarcoma of the liver: imaging features and clinical findings in six cases and a review of the literature.
    Li J; Liang P; Zhang D; Liu J; Zhang H; Qu J; Gao J
    Cancer Imaging; 2018 Feb; 18(1):7. PubMed ID: 29482629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Next-generation sequencing analysis identifies genomic alterations in pathological morphologies: A case of pulmonary carcinosarcoma harboring EGFR mutations.
    Koba H; Kimura H; Nishikawa S; Sone T; Abo M; Hara J; Hosomichi K; Tajima A; Kasahara K
    Lung Cancer; 2018 Aug; 122():146-150. PubMed ID: 30032823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The genetic landscape of metaplastic breast cancers and uterine carcinosarcomas.
    Moukarzel LA; Ferrando L; Da Cruz Paula A; Brown DN; Geyer FC; Pareja F; Piscuoglio S; Papanastasiou AD; Fusco N; Marchiò C; Abu-Rustum NR; Murali R; Brogi E; Wen HY; Norton L; Soslow RA; Vincent-Salomon A; Reis-Filho JS; Weigelt B
    Mol Oncol; 2021 Apr; 15(4):1024-1039. PubMed ID: 33021035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In-depth molecular profiling of the biphasic components of uterine carcinosarcomas.
    McConechy MK; Hoang LN; Chui MH; Senz J; Yang W; Rozenberg N; Mackenzie R; McAlpine JN; Huntsman DG; Clarke BA; Gilks CB; Lee CH
    J Pathol Clin Res; 2015 Jul; 1(3):173-85. PubMed ID: 27499902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two Components of Variant Profiles in Primary Vaginal Carcinosarcoma via Next-Generation Sequencing and a Literature Review.
    Kotoku R; Yanazume S; Kuroda T; Kobayashi Y; Kitazono I; Akahane T; Tanimoto A; Kobayashi H
    Int J Surg Pathol; 2022 May; 30(3):288-294. PubMed ID: 34463147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary carcinosarcoma of the liver: clinicopathologic features of 5 cases and a review of the literature.
    Lao XM; Chen DY; Zhang YQ; Xiang J; Guo RP; Lin XJ; Li JQ
    Am J Surg Pathol; 2007 Jun; 31(6):817-26. PubMed ID: 17527068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Esophageal carcinosarcoma with basaloid squamous carcinoma and rhabdomyosarcoma components with TP53 mutation.
    Amatya VJ; Takeshima Y; Kaneko M; Inai K
    Pathol Int; 2004 Oct; 54(10):803-9. PubMed ID: 15482572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salivary gland carcinosarcoma: oligonucleotide array CGH reveals similar genomic profiles in epithelial and mesenchymal components.
    Vékony H; Leemans CR; Ylstra B; Meijer GA; van der Waal I; Bloemena E
    Oral Oncol; 2009 Mar; 45(3):259-65. PubMed ID: 18693132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparing Clonality Between Components of Combined Hepatocellular Carcinoma and Cholangiocarcinoma by Targeted Sequencing.
    Jeon J; Maeng LS; Bae YJ; Lee EJ; Yoon YC; Yoon N
    Cancer Genomics Proteomics; 2018; 15(4):291-298. PubMed ID: 29976634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic alterations in urinary bladder carcinosarcoma: evidence of a common clonal origin.
    Halachmi S; DeMarzo AM; Chow NH; Halachmi N; Smith AE; Linn JF; Nativ O; Epstein JI; Schoenberg MP; Sidransky D
    Eur Urol; 2000 Mar; 37(3):350-7. PubMed ID: 10720865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequent genetic heterogeneity in the clonal evolution of gynecological carcinosarcoma and its influence on phenotypic diversity.
    Fujii H; Yoshida M; Gong ZX; Matsumoto T; Hamano Y; Fukunaga M; Hruban RH; Gabrielson E; Shirai T
    Cancer Res; 2000 Jan; 60(1):114-20. PubMed ID: 10646862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.